Johnson & Johnson's CEO highlights America's leading role in biopharmaceutical innovation, with U.S. companies driving 55% of global R&D and launching most new medicines. Artificial intelligence is accelerating drug discovery and clinical trials, while also enhancing clinical judgment and surgical precision. The company is investing over $55 billion in U.S. research and manufacturing over the next four years to maintain this leadership and ensure accessibility of treatments. AI
影响 AI is accelerating drug discovery and clinical trials, and enhancing clinical judgment and surgical precision in healthcare.
排序理由 This is a commentary piece from a CEO discussing industry trends and company investment, not a direct release of a new product or research.
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
